Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

The new wound dressing improves healing and tissue repair better than conventional dressings.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Combining narrow-band ultraviolet B light and stem cell transplantation helps repigmentation in vitiligo by maintaining calcium balance in mice.

Liver stem cells keep their basic functions even in inflamed liver tissue.

Vitamin A helps skin stem cells decide their function, aiding in hair growth and wound repair.

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Non-drug therapies show promise for hair regrowth but need more research.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Anti-CD19 therapy may help treat SLE and NMOSD.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Zinc may help treat alopecia areata by boosting certain immune cells.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.